E
Overview
Empo Health provides a diabetic foot ulcer (DFU) management system that combines an in-home imaging scale with a digital health portal. Patients use the Empo Footprint to capture foot images at home, and clinicians monitor the data through the Empo Remote Health Link to detect issues early. Unlike clinic-only care, this at-home tool paired with remote monitoring enables ongoing oversight and timely intervention between visits. The goal is to prevent ulcers from worsening, reduce amputations, and lower healthcare costs, supported by a recent $7 million funding round to launch the product.
Work here?Claim your company
Simplify's take
What believers are saying
- June 2025's $7 million round funded commercialization and launch execution.
- The platform fits existing reimbursement pathways, easing provider adoption.
- Near-daily engagement in pilots supports recurring monitoring, clinician workflow, and payer value narratives.
What critics are saying
- Empo's July 2026 evidence came from 21 patients across three podiatry practices.
- Revenue depends on reimbursement pathways and value-based care adoption by insurers and providers.
- If CMS-aligned utilization fails, Empo becomes a niche device seller with stalled commercialization.
What makes Empo Health unique
- Empo pairs FDA-listed Footprint hardware with Remote Health Link for closed-loop DFU monitoring.
- July 2026 JMIR study showed 97.7% scan acceptability across 3,295 home scans.
- APMA Seal of Approval and SOC 2 Type 2 strengthen clinical and security credibility.
Help us improve and share your feedback! Did you find this helpful?